HAVN Life Sciences Inc. (OTCMKTS:HAVLF) Sees Significant Decline in Short Interest

HAVN Life Sciences Inc. (OTCMKTS:HAVLF) was the recipient of a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 1,300 shares, a decline of 92.1% from the February 29th total of 16,500 shares. Based on an average trading volume of 11,900 shares, the short-interest ratio is presently 0.1 days.

HAVN Life Sciences Price Performance

OTCMKTS:HAVLF remained flat at $0.02 during mid-day trading on Thursday. The company had a trading volume of 41 shares, compared to its average volume of 7,258. The business’s fifty day moving average price is $0.02 and its two-hundred day moving average price is $0.02. HAVN Life Sciences has a 1 year low of $0.01 and a 1 year high of $0.15.

HAVN Life Sciences Company Profile

HAVN Life Sciences Inc, a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp.